Access and Co-pay Assistance - VYVGART Hytrulo
ClosedLink broken·Sep 14, 2026
- Covers
- financial assistance
- Max award
- $25,000
- Enrollment cycle
- rolling
Eligibility
Eligible patients must have commercial insurance and a valid prescription for an on-label indication of VYVGART or VYVGART Hytrulo. The program provides up to $25,000 per calendar year to cover out-of-pocket drug and administration costs.
Apply
Application goes directly to the program. RxCopays does not receive compensation.
Go to application →Status source
Automated check 2026-08-28T05:00:51.332Z: application_url + organization_url return 404/DNS-fail. Grant may have ended. Please submit a correction via /add-resource if this is incorrect.
Rare-disease support beyond financial help
This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: